Patient and public involvement and engagement in the ASCEND PLUS trial: reflections from the design of a streamlined and decentralised clinical trial

Introduction: ASCEND PLUS is a randomised controlled trial assessing the effects of oral semaglutide on the primary prevention of cardiovascular events in around 20,000 individuals with type 2 diabetes in the UK. The trial’s innovative design includes a decentralised direct-to-participant invitation...

Full description

Bibliographic Details
Main Authors:	El-Nayir, M, Wijesurendra, R, Preiss, D, Mafham, M, Tsiotos, L, Islam, S, Whitehouse, A, Wilkinson, S, Freeman, H, Lee, R, Brudlo, W, Bobby, G, Jenkins, B, Humphrey, R, Mallorie, A, Toal, A, Barker, EC, Moylan, D, Thomson, G, Davies, F, Khan, H, Allotey, I, Dickie, S, Roberts, J
Format:	Journal article
Language:	English
Published:	BioMed Central 2024

Patient and public involvement and engagement in the ASCEND PLUS trial: reflections from the design of a streamlined and decentralised clinical trial

Similar Items